Novo Nordisk Quote - NOV

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

85.42

Bid

85.42

Ask

85.47

Volume

126,638

77.41 Day's Range 86.89

9.6779 52 Week Range 139.88

Market Cap

384.049B

Previous Close

77.94

Open

78.25

Last Trade

85.42

Last Trade Time

05:29:51

Financial Volume

VWAP

Average Volume (3m)

133,709

Shares Outstanding

4,496,011,436

Dividend Yield

86.47%

PE Ratio

4.46

Earnings Per Share (EPS)

18.61

Revenue

232.26B

Net Profit

83.68B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novonordisk.com

Headquarters

Bagsvaerd, Dnk

Founded

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 77.94 €. Over the last year, Novo Nordisk shares have traded in a share price range of 9.6779 € to 139.88 €.

Novo Nordisk currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk is 350.42 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.46.

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity Bagsværd, Denmark, 24 January 2025 – Novo Nordisk today announced topline...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence Bagsværd, Denmark, 17 January 2025 – Novo Nordisk...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 13 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases Scope of collaboration originally signed in 2023 will significantly expand...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced...

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed Bagsværd, Denmark, 18 December 2024 — Today...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.430001	5.46981239005	80.989999	86.89	73.72	236044	76.83722557	DE
4	-0.59	-0.685966748053	86.01	86.89	9.6778999	173456	80.42391567	DE
12	-17	-16.5983206405	102.42	110	9.6778999	133709	88.66424736	DE
26	-38.2	-30.9011486814	123.62	126.32	9.6778999	92742	97.94368796	DE
52	-12.07	-12.3807570007	97.49	139.88	9.6778999	81300	107.20346825	DE
156	-6.28	-6.84841875682	91.7	139.88	9.6778999	76051	104.04062492	DE
260	-6.28	-6.84841875682	91.7	139.88	9.6778999	76051	104.04062492	DE

NOV - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?

The current share price of Novo Nordisk is 85.42 €

How many Novo Nordisk shares are in issue?

Novo Nordisk has 4,496,011,436 shares in issue

What is the market cap of Novo Nordisk?

The market capitalisation of Novo Nordisk is EUR 350.42B

What is the 1 year trading range for Novo Nordisk share price?

Novo Nordisk has traded in the range of 9.6779 € to 139.88 € during the past year

What is the PE ratio of Novo Nordisk?

The price to earnings ratio of Novo Nordisk is 4.46

What is the cash to sales ratio of Novo Nordisk?

The cash to sales ratio of Novo Nordisk is 1.61

What is the reporting currency for Novo Nordisk?

Novo Nordisk reports financial results in DKK

What is the latest annual turnover for Novo Nordisk?

The latest annual turnover of Novo Nordisk is DKK 232.26B

What is the latest annual profit for Novo Nordisk?

The latest annual profit of Novo Nordisk is DKK 83.68B

What is the registered address of Novo Nordisk?

The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880

What is the Novo Nordisk website address?

The website address for Novo Nordisk is www.novonordisk.com

Which industry sector does Novo Nordisk operate in?

Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
49YAvenue Therapeutics Inc	2.84 € (61.36%)	300
VAR1Varta AG	1.012 € (39.59%)	2.3M
W1HOnco Innovations Limited	1.94 € (34.16%)	1.58M
L7C2Windfall Geotek Inc	0.011 € (29.41%)	3.94k
L09Lithium Energi Exploration Inc	0.0245 € (28.95%)	7k
E3O1Nexoptic Technology Corp	0.008 € (-48.39%)	33.96k
UH7ATennant Minerals NL	0.005 € (-41.18%)	6.42k
BDDOrdinary Shares	0.0036 € (-37.93%)	9k
PA8Paion AG	0.0152 € (-29.63%)	1.04k
K1SNKlondike Silver Corporation	0.008 € (-23.81%)	20k
PF8European Lithium Limited	0.0302 € (-16.11%)	5.73M
VAR1Varta AG	1.012 € (39.59%)	2.3M
0QJHexagon Purus ASA	0.269 € (-23.58%)	1.98M
W1HOnco Innovations Limited	1.94 € (34.16%)	1.58M
D7GNel ASA	0.1948 € (1.83%)	1.49M